Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • clovip
    Junior Member
    • Jun 2008
    • 3

    The Brain & Spine Institute (ICM) recruits five engineers in bioinformatics

    The Brain & Spine Institute (ICM, Paris) recruits five engineers in bioinformatics

    You aspire to contribute, in a cutting-edge scientific and clinical environment, to the advancement of brain knowledge, and to the discovery of new diagnostic and therapeutic strategies for neurological disorders.

    The ICM bioinformatics & biostatistics core facility, at the Pitié-Salpêtrière Hospital in Paris, is strengthening and diversifying its activities.
    Comprising six staff members, including two research associates specialized in genome bioinformatics, the facility recruits five new bioinformaticians for the following missions:
    • Treatment and interpretation of genomic, transcriptomic and epigenomic data from high-throughput sequencing – 3 positions (open to junior or experienced candidates)
    • Methodological and software development for new applications (complete genomes, methylation profiles) – 2 positions


    Depending on each position, the associated tasks include several components, going from the development and implementation of pipelines and web interfaces, to users advice, support and training.

    PROFILES:
    • Knowledge: expertise in the analysis of omics data of higher eukaryotes (bioinformatics methods and data) and/or skills in software engineering (algorithmic, programming, high-performance computing)
    • Professional experience: beginners and skilled candidates welcomed
    • Degrees: MSc-level degree in bioinformatics / computer science or equivalent level

    POSITIONS:
    • Contracts: fixed-term (CDD)
    • Salary: depending on experience
    • Starting date: as soon as possible
    • Location: ICM, Hôpital Pitié-Salpêtrière, 75013 PARIS, FRANCE – http://icm-institute.org/en/

    Send CV and cover letter to:
    [email protected] and [email protected]

    Deadline for applications: June 1st, 2017.

    The Brain & Spine Institute (ICM) is a private state-approved non-profit foundation, dedicated to basic and clinical neuroscience research. Part of the largest European hospital and a top-level French university, the ICM gathers in the same building 600 researchers and clinicians covering the full spectrum of neurosciences, who collaborate to accelerate discoveries on the functioning of the brain and the development of treatments for diseases such as: Alzheimer, Parkinson, multiple sclerosis, epilepsy, depression or paraplegias. The ICM is located at the heart of Paris and offers a unique environment associating core technological facilities, space for industrial partners and a center for clinical investigations. This environment has attracted the best international research groups.
    Last edited by clovip; 04-28-2017, 03:11 PM.

Latest Articles

Collapse

  • SEQadmin2
    Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by SEQadmin2


    I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.


    Here are nine questions we think about, in roughly the order they matter, before...
    Yesterday, 07:11 AM
  • SEQadmin2
    From Collection to Sequencing: Why Sample Preparation and Preservation Define Sequencing Data
    by SEQadmin2


    Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.


    The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
    ...
    06-02-2026, 10:05 AM
  • SEQadmin2
    Single-Cell Sequencing at an Inflection Point: Early Impacts of New Platforms and Emerging Trends
    by SEQadmin2


    With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.


    Introduction

    Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...
    05-22-2026, 06:42 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 06-17-2026, 06:09 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 06-09-2026, 11:58 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 06-05-2026, 10:09 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 06-04-2026, 08:59 AM
0 responses
49 views
0 reactions
Last Post SEQadmin2  
Working...